Weiss Multi-Strategy Advisers
LRMR icon

Weiss Multi-Strategy Advisers’s Larimar Therapeutics LRMR Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,500
Closed -$925K – 487
2014
Q4 		$925K Sell
2,500
-1,250
-33% -$322K 0.03% 292
2014
Q3 		$884K Buy
+3,750
New +$850K 0.02% 391

Other funds holding LRMR

TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Janus Henderson Investors US
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Weiss Multi-Strategy Advisers's LRMR Position: Q1 2015 in Review

Weiss Multi-Strategy Advisers sold out of Larimar Therapeutics (LRMR) in Q1 2015, closing a stake of 2,500 shares — an estimated $925K sold.

Weiss Multi-Strategy Advisers first reported a position in LRMR in Q3 2014 and held it in 2 quarters. The position peaked at $925K in Q4 2014. 93 funds tracked by Wall St. Rank hold LRMR as of Q1 2015.

  • Weiss Multi-Strategy Advisers reported no remaining Larimar Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 2,500 Larimar Therapeutics shares in Q1 2015, an estimated $925K.
  • Weiss Multi-Strategy Advisers first reported a position in Larimar Therapeutics in Q3 2014 and held it in 2 quarters.
  • Weiss Multi-Strategy Advisers's Larimar Therapeutics position peaked at $925K in Q4 2014.
  • 93 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2015.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2015, filed 15 May 2015.